Valuation: Hansoh Pharmaceutical Group Company Limited

Capitalization 223B 250B 32.06B 27.54B 25.55B 23.87B 44.45B 2,914B 47.76B 295B 116B 1,387B 120B 118B 5,069B P/E ratio 2025 *
42.9x
P/E ratio 2026 * 40.5x
Enterprise value 197B 221B 28.29B 24.3B 22.55B 21.07B 39.22B 2,571B 42.14B 261B 103B 1,224B 106B 104B 4,473B EV / Sales 2025 *
13.4x
EV / Sales 2026 * 12.1x
Free-Float
18.75%
Yield 2025 *
0.84%
Yield 2026 * 0.88%
More valuation ratios * Estimated data
Dynamic Chart
1 day-4.00%
1 week+1.57%
Current month+14.41%
1 month+7.22%
3 months+13.34%
6 months+14.99%
Current year+14.41%
More quotes
1 week 40.6
Extreme 40.6
44.22
1 month 35.54
Extreme 35.54
44.22
Current year 35.7
Extreme 35.7
44.22
1 year 16.7
Extreme 16.7
44.22
3 years 9.41
Extreme 9.41
44.22
5 years 9.41
Extreme 9.41
46.7
10 years 9.41
Extreme 9.41
46.7
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 01/12/2015
Corporate Secretary 37 25/12/2025
Corporate Secretary 58 31/07/2018
Director TitleAgeSince
Chairman 65 01/12/2015
Director/Board Member 49 10/03/2016
Director/Board Member 39 01/12/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-4.00%+1.57%+143.11%+148.08% 33.38B
+0.53%-2.37%+43.09%+194.99% 930B
-0.41%+6.98%+48.72%+28.81% 527B
-1.11%-2.60%+24.94%+43.67% 379B
-0.60%+1.26%+29.94%+17.78% 371B
-1.15%-1.63%+28.68%+21.63% 292B
-0.03%+1.51%+29.51%+36.74% 276B
-1.93%-1.54%+11.14%+0.04% 270B
-2.92%-0.41%-31.52%-21.19% 268B
+0.12%+1.32%+21.43%+24.97% 178B
Average -1.19%+0.97%+34.90%+49.55% 352.43B
Weighted average by Cap. -0.64%+0.53%+30.06%+68.04%
See all sector performances

Financials

2025 *2026 *
Net sales 14.69B 16.45B 2.11B 1.81B 1.68B 1.57B 2.92B 192B 3.14B 19.43B 7.65B 91.28B 7.91B 7.75B 334B 15.96B 17.87B 2.29B 1.97B 1.83B 1.71B 3.18B 208B 3.41B 21.11B 8.31B 99.17B 8.6B 8.42B 362B
Net income 5.05B 5.66B 726M 623M 578M 540M 1.01B 65.93B 1.08B 6.68B 2.63B 31.39B 2.72B 2.67B 115B 5.43B 6.08B 780M 670M 622M 581M 1.08B 70.9B 1.16B 7.18B 2.83B 33.76B 2.93B 2.87B 123B
Net Debt -26.26B -29.4B -3.77B -3.24B -3.01B -2.81B -5.23B -343B -5.62B -34.72B -13.67B -163B -14.14B -13.85B -596B -30.26B -33.88B -4.35B -3.73B -3.46B -3.24B -6.02B -395B -6.47B -40.01B -15.76B -188B -16.3B -15.96B -687B
More financial data * Estimated data
Logo Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.
Employees
9,313
More about the company
Date Price Change Volume
19/01/26 41.28 $ -4.00% 6,031,453
16/01/26 43.00 $ -0.28% 3,706,567
15/01/26 43.12 $ +0.42% 6,370,691
14/01/26 42.94 $ +2.14% 10,159,880
13/01/26 42.04 $ +3.44% 5,989,850

Delayed Quote Hong Kong S.E., January 19, 2026 at 08:08 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
36.88CNY
Average target price
40.67CNY
Spread / Average Target
+10.27%
Consensus

Quarterly revenue - Rate of surprise